Trial Profile

A multicenter, single blind Phase I/IIa study of IFNalpha Kinoid in dermatomyositis.

Status: Recruiting

Phase of Trial: Phase I/II

Latest Information Update: 31 Oct 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Interferon alpha kinoid (Primary)
Indications Dermatomyositis
Focus Adverse reactions; Therapeutic Use

Most Recent Events

31 Oct 2017 Status changed from planning to recruiting.
31 Oct 2017 New trial record
27 Oct 2017 According to a Neovacs media release, the company obtained U.S. FDA's acceptance of IND to expand this study into US. The study currently recruiting in European countries.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com